LncRNA HCG18 Suppresses CD8⁺ T Cells to Confer Resistance to Cetuximab in Colorectal Cancer Via miR-20b-5p/PD-L1 Axis

References

• Dekker E , TanisPJ , VleugelsJLA , KasiPM , WallaceMB. Colorectal cancer. Lancet394(10207), 1467–1480 (2019).
   PubMed Web of Science ®Google Scholar
• Jiao S , PetersU , BerndtSet al. Estimating the heritability of colorectal cancer. Hum. Mol. Genet.23(14), 3898–3905 (2014).
   PubMed Web of Science ®Google Scholar
• Stintzing S , FischerVon Weikersthal L , DeckerTet al. FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer-subgroup analysis of patients with KRAS: mutated tumours in the randomised German AIO study KRK-0306. Ann. Oncol.23(7), 1693–1699 (2012).
   PubMed Web of Science ®Google Scholar
• Cremolini C , RossiniD , Dell’AquilaEet al. Rechallenge for patients with RAS and BRAF wild-type metastatic colorectal cancer with acquired resistance to first-line cetuximab and irinotecan: a Phase II single-arm clinical trial. JAMA Oncol.5(3), 343–350 (2019).
   PubMed Web of Science ®Google Scholar
• Gubin MM , ZhangX , SchusterHet al. Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens. Nature515(7528), 577–581 (2014).
   PubMed Web of Science ®Google Scholar
• Quezada SA , PeggsKS , SimpsonTR , AllisonJP. Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication. Immunol. Rev.241(1), 104–118 (2011).
   PubMed Web of Science ®Google Scholar
• Wang X , LiJ , DongKet al. Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia. Cell. Signal.27(3), 443–452 (2015).
   PubMed Web of Science ®Google Scholar
• Napolitano S , MartiniG , RinaldiBet al. Primary and acquired resistance of colorectal cancer to anti-EGFR monoclonal antibody can be overcome by combined treatment of regorafenib with cetuximab. Clin. Cancer Res.21(13), 2975–2983 (2015).
   PubMed Web of Science ®Google Scholar
• Woolston A , KhanK , SpainGet al. Genomic and transcriptomic determinants of therapy resistance and immune landscape evolution during anti-EGFR treatment in colorectal cancer. CancerCell36(1), 35–50 (2019).
   Web of Science ®Google Scholar
• Barbier J , ChenX , SanchezGet al. An NF90/NF110-mediated feedback amplification loop regulates dicer expression and controls ovarian carcinoma progression. Cell. Res.28(5), 556–571 (2018).
   PubMed Web of Science ®Google Scholar
• Zhu H , JinYM , LyuXM , FanLM , WuF. Long noncoding RNA H19 regulates HIF-1alpha/AXL signaling through inhibiting miR-20b-5p in endometrial cancer. Cell Cycle18(19), 2454–2464 (2019).
   PubMed Web of Science ®Google Scholar
• Li Y , ChenD , JinLet al. MicroRNA-20b-5p functions as a tumor suppressor in renal cell carcinoma by regulating cellular proliferation, migration and apoptosis. Mol. Med. Rep.13(2), 1895–1901 (2016).
   PubMed Web of Science ®Google Scholar
• Li M , ZhouY , XiaTet al. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer. Breast Cancer Res. Treat.170(2), 257–270 (2018).
   PubMed Web of Science ®Google Scholar
• Tang D , YangZ , LongFet al. Long noncoding RNA MALAT1 mediates stem cell-like properties in human colorectal cancer cells by regulating miR-20b-5p/Oct4 axis. J. Cell. Physiol.234(11), 20816–20828 (2019).
   PubMed Web of Science ®Google Scholar
• Fang Y , FullwoodMJ. Roles, functions, and mechanisms of long non-coding RNAs in cancer. Genomics Proteomics Bioinformatics14(1), 42–54 (2016).
   PubMed Web of Science ®Google Scholar
• Ponting CP , OliverPL , ReikW. Evolution and functions of long noncoding RNAs. Cell136(4), 629–641 (2009).
   PubMed Web of Science ®Google Scholar
• Ma F , AnK , LiY. Silencing of long non-coding RNA-HCG18 inhibits the tumorigenesis of gastric cancer through blocking PI3K/Akt pathway. Onco. Targets Ther.13, 2225–2234 (2020).
   PubMed Web of Science ®Google Scholar
• Zou Y , SunZ , SunS. LncRNA HCG18 contributes to the progression of hepatocellular carcinoma via miR-214-3p/CENPM axis. J. Biochem. doi:10.1093/jb/mvaa073 (2020) ( Epub ahead of print).
   Google Scholar
• Li S , WuT , ZhangD , SunX , ZhangX. The long non-coding RNA HCG18 promotes the growth and invasion of colorectal cancer cells through sponging miR-1271 and upregulating MTDH/Wnt/beta-catenin. Clin. Exp. Pharmacol. Physiol.47(4), 703–712 (2020).
   PubMed Web of Science ®Google Scholar
• Livak KJ , SchmittgenTD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods25(4), 402–408 (2001).
   PubMed Web of Science ®Google Scholar
• Lu Y , ZhaoX , LiuQet al. lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/beta-catenin signaling. Nat. Med.23(11), 1331–1341 (2017).
   PubMed Web of Science ®Google Scholar
• Zhao B , WangL , QiuHet al. Mechanisms of resistance to anti-EGFR therapy in colorectal cancer. Oncotarget8(3), 3980–4000 (2017).
   PubMedGoogle Scholar
• Bertotti A , PappE , JonesSet al. The genomic landscape of response to EGFR blockade in colorectal cancer. Nature526(7572), 263–267 (2015).
   PubMed Web of Science ®Google Scholar
• Ikebuchi R , KonnaiS , OkagawaTet al. Influence of PD-L1 cross-linking on cell death in PD-L1-expressing cell lines and bovine lymphocytes. Immunology142(4), 551–561 (2014).
   PubMed Web of Science ®Google Scholar
• Momtaz P , PostowMA. Influence of PD-L1 cross-linking on cell death in PD-L1-expressing cell lines and bovine lymphocytes. Pharmgenomics Pers. Med.7, 357–365 (2014).
   PubMedGoogle Scholar
• Jing C , MaR , CaoHet al. Long noncoding RNA and mRNA profiling in cetuximab-resistant colorectal cancer cells by RNA sequencing analysis. Cancer Med.8(4), 1641–1651 (2019).
   PubMed Web of Science ®Google Scholar
• Bonomo P , DesideriI , LoiMet al. Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: a Phase I/II study (DUCRO). Clin. Transl. Radiat. Oncol.9, 42–47 (2018).
   PubMedGoogle Scholar